Vimarsana
Biggest News Aggregation in the World

Page 5 - Feng Ren News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Feng Ren. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Feng Ren Today - Breaking & Trending Today

In just 30 days, artificial intelligence discovers a cure for cancer! - Vimarsana News

In just 30 days, artificial intelligence discovers a cure for cancer!

Artificial intelligence has developed a cure for an aggressive form of cancer in just 30 days and has shown that it can predict patient survival using

AI develops cancer drug in just 30 days, predicts patients' life expectancy based on medical notes - Vimarsana News

AI develops cancer drug in just 30 days, predicts patients' life expectancy based on medical notes

Medical researchers in Canada used AI to develop a treatment for a type of cancer in just 30 days. Another group of scientists working with cancer patients developed a ChatGPT-like AI bot that predicts the life expectancy and survival rate of cancer patients.

AI Discovers Potential New Cancer Treatment In Just 30 Days - Vimarsana News

AI Discovers Potential New Cancer Treatment In Just 30 Days

Researchers from the Univ. of Toronto and Insilico Medicine used an AI-powered database to create a drug that could potentially treat liver cancer.

AI develops cancer drug in 30 days - and predicts survival rates - Vimarsana News

AI develops cancer drug in 30 days - and predicts survival rates

AI has proven it is more useful than just generating images and text, two new models are revolutionizing the medical industry with new cancer drugs and live expectancy predictions of patients.

AlphaFold and AI Accelerate Design of New Liver Cancer Drug - Vimarsana News

AlphaFold and AI Accelerate Design of New Liver Cancer Drug

A new study has successfully used AlphaFold, an artificial intelligence (AI)-powered protein structure database, to accelerate the design and synthesis of a drug to treat the most common type of primary liver cancer.